Workflow
盈利预测修正趋势
icon
Search documents
Monro (MNRO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2026-03-02 15:56
Shares of Monro Muffler Brake (MNRO) have been struggling lately and have lost 5.5% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case ...
Esab (ESAB) Soars 8.3%: Is Further Upside Left in the Stock?
ZACKS· 2026-02-05 13:32
Company Overview - ESAB shares increased by 8.3% to $127.61 in the last trading session, with a higher-than-average trading volume, compared to a 1.2% gain over the past four weeks [1] - The company announced a definitive agreement to acquire Eddyfi Technologies, which is expected to expand its addressable market by $5 billion, enhancing its presence in high-growth sectors such as Aerospace and Defense, Nuclear, Energy, and Civil Infrastructure [2] Financial Performance - ESAB is projected to report quarterly earnings of $1.33 per share, reflecting a year-over-year increase of 3.9%, with expected revenues of $687.7 million, up 8.6% from the previous year [3] - The consensus EPS estimate for the upcoming quarter has been revised marginally lower over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Industry Context - ESAB holds a Zacks Rank of 3 (Hold) within the Metal Products - Procurement and Fabrication industry, while TriMas (TRS), another company in the same sector, closed 0.3% higher at $35.04, with a return of -1.6% over the past month [5] - TriMas' consensus EPS estimate for the upcoming report remains unchanged at $0.41, representing a year-over-year decline of 4.7%, and it currently holds a Zacks Rank of 2 (Buy) [6]
Halliburton (HAL) Soars 7.8%: Is Further Upside Left in the Stock?
ZACKS· 2026-01-06 10:15
Core Viewpoint - Halliburton's shares experienced a significant increase of 7.8% to close at $31.92, driven by strong trading volume and optimism regarding potential investments in Venezuela's oil sector [1][2]. Company Performance - Halliburton is expected to report quarterly earnings of $0.54 per share, reflecting a year-over-year decline of 22.9%. Revenue is anticipated to be $5.39 billion, down 3.9% from the previous year [3]. - The consensus EPS estimate for Halliburton has been revised slightly higher in the last 30 days, indicating a positive trend that may lead to price appreciation [4]. Market Sentiment - The increase in Halliburton's stock price is linked to optimism surrounding U.S. actions towards Venezuela, which could lead to increased oil production and subsequently benefit oilfield service providers [2]. - The sentiment was further bolstered by Donald Trump's encouragement for U.S. oil companies to invest in rebuilding Venezuela's oil infrastructure [2]. Industry Context - Halliburton operates within the Zacks Oil and Gas - Field Services industry, which includes other companies like FMC Technologies, that also saw a stock increase of 2.1% [5]. - FMC Technologies has a consensus EPS estimate of $0.51, representing a decline of 5.6% from the previous year, and currently holds a Zacks Rank of 2 (Buy) [6].
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains?
ZACKS· 2025-12-22 13:16
Core Insights - Illumina's shares increased by 3.3% to close at $134.78, with notable trading volume, and a total gain of 9.4% over the past four weeks [1][2] Company Performance - Illumina is expected to report quarterly earnings of $1.22 per share, reflecting a year-over-year increase of 41.9%, while revenues are projected to be $1.1 billion, a slight decrease of 0.3% from the previous year [3] - The consensus EPS estimate for Illumina has been revised marginally higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Industry Context - Illumina operates within the Zacks Medical - Biomedical and Genetics industry, where Regeneron, another company in the same sector, saw a 2.6% increase in its stock price, closing at $767.96, with a 1.6% return over the past month [4] - Regeneron's consensus EPS estimate has decreased by 2.8% over the past month to $10.48, representing a year-over-year decline of 13.2%, and it currently holds a Zacks Rank of 3 (Hold) [5]
Huntington Ingalls (HII) Moves 4.3% Higher: Will This Strength Last?
ZACKS· 2025-12-22 13:06
Core Viewpoint - Huntington Ingalls Industries (HII) has seen a significant increase in stock price, driven by strong trading volume and positive market sentiment following a key contract announcement with the U.S. Navy [1][2]. Group 1: Stock Performance - HII shares rose 4.3% in the last trading session, closing at $336.64, with a total gain of 6.9% over the past four weeks [1]. - The stock's recent performance is supported by solid trading volume, indicating heightened investor interest [1]. Group 2: Contract Announcement - On December 19, 2025, HII's Ingalls Shipbuilding unit was awarded a contract by the U.S. Navy to design and build a future small surface combatant ship, enhancing HII's naval shipbuilding portfolio [2]. - This contract is based on the established Legend-class national security cutter design, which is expected to provide steady workload visibility for Ingalls Shipbuilding operations [2]. Group 3: Company Position and Market Role - Huntington Ingalls is a major industrial employer in Virginia and is pivotal in U.S. naval shipbuilding, being the only company in the U.S. that designs and builds nuclear-powered aircraft carriers [3]. - More than 70% of the active U.S. Navy fleet consists of ships built by HII, underscoring its critical role in national defense [3]. Group 4: Earnings Expectations - HII is projected to report quarterly earnings of $3.75 per share, reflecting a year-over-year increase of 19.1%, with revenues expected to reach $3.05 billion, up 1.6% from the previous year [4]. - The consensus EPS estimate for HII has been revised slightly higher in the last 30 days, indicating a positive trend that may lead to further stock price appreciation [5]. Group 5: Industry Context - HII operates within the Zacks Aerospace - Defense industry, where it holds a Zacks Rank of 3 (Hold) [5]. - General Dynamics, a competitor in the same industry, has a consensus EPS estimate of $4.11, unchanged over the past month, and also holds a Zacks Rank of 3 (Hold) [6].
Strength Seen in BayCom Corp (BCML): Can Its 6.4% Jump Turn into More Strength?
ZACKS· 2025-12-15 12:31
Core Insights - BayCom Corp (BCML) shares have experienced a significant increase, ending the last trading session at $32.78, which is a 6.4% rise, and an 8.5% gain over the past four weeks [1][2] - The stock reached a new 52-week high of $32.98, driven by improved investor sentiment towards bank stocks following the Federal Reserve's third interest-rate cut of the year, which is expected to enhance loan demand and reduce funding costs [2] - BayCom Corp is projected to report quarterly earnings of $0.65 per share, reflecting an 18.2% year-over-year increase, with revenues anticipated at $26.3 million, up 11.2% from the previous year [3] Earnings and Estimates - The consensus EPS estimate for BayCom Corp has remained stable over the last 30 days, indicating that the stock's price movement may not sustain without changes in earnings estimate revisions [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4] Industry Context - BayCom Corp is part of the Zacks Banks - West industry, which has shown positive performance, with Western Alliance (WAL) also experiencing a slight increase of 0.1% to $87.59 and a return of 11.9% over the past month [4] - Western Alliance's consensus EPS estimate has remained unchanged at $2.46, representing a 26.2% increase from the previous year, and it also holds a Zacks Rank of 3 (Hold) [5]
BWX (BWXT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
ZACKS· 2025-11-11 15:55
Core Viewpoint - BWX Technologies (BWXT) has experienced a bearish trend recently, losing 7.9% in stock price over the past week, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottom in the stock price, suggesting that selling pressure may be exhausting. This pattern forms when there is a small candle body with a long lower wick, indicating that buyers are starting to emerge after a downtrend [4][5]. - The hammer pattern is more significant when it appears at the bottom of a downtrend, signaling that bears may be losing control and that a trend reversal could be imminent [5]. Fundamental Analysis - Recent upward revisions in earnings estimates for BWXT serve as a bullish indicator, correlating strongly with potential near-term stock price movements. Over the last 30 days, the consensus EPS estimate for the current year has increased by 1.6%, indicating analysts expect better earnings than previously predicted [7][8]. - BWXT holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises. Stocks with a Zacks Rank of 1 or 2 typically outperform the market [9][10].
Capri Holdings (CPRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
ZACKS· 2025-11-04 15:56
Core Viewpoint - Capri Holdings (CPRI) has experienced a bearish trend recently, losing 8.1% over the past week, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottoming out, with selling pressure likely subsiding, which could lead to a bullish trend for the stock [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, signaling that bears may be losing control and bulls are starting to gain traction [4][5]. - This pattern can occur across various timeframes and is utilized by both short-term and long-term investors [5]. Fundamental Analysis - There is a strong consensus among Wall Street analysts to raise earnings estimates for Capri Holdings, which supports the bullish case for the stock [2][7]. - Over the last 30 days, the consensus EPS estimate for the current year has increased by 1.5%, indicating that analysts expect better earnings than previously predicted [8]. - Capri Holdings currently holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10]. Conclusion - The combination of the hammer chart pattern and positive earnings estimate revisions suggests that Capri Holdings may be on the verge of a trend reversal, making it a stock to watch for potential investment opportunities [1][7][10].
Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock?
ZACKS· 2025-10-10 13:56
Company Overview - Oculis Holding AG (OCS) shares increased by 6.3% to $21.13 in the last trading session, with a notable trading volume, and have gained 15.4% over the past four weeks [1][2] Recent Developments - The company has advanced its pipeline candidate, privosegtor, into a registrational program for neuro-ophthalmology indications following a positive meeting with the FDA. Oculis will initiate three pivotal studies for privosegtor targeting acute optic neuritis and non-arteritic anterior ischemic optic neuropathy, which likely contributed to the recent share price increase [2] Financial Expectations - Oculis is projected to report a quarterly loss of $0.50 per share, reflecting a year-over-year change of +9.1%. Expected revenues are $0.25 million, down 1.6% from the same quarter last year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Oculis is part of the Zacks Medical - Biomedical and Genetics industry. Another company in the same sector, Qiagen (QGEN), saw a 1.7% decline in its stock price, closing at $46.93, with a 3.8% return over the past month [5] - Qiagen's consensus EPS estimate has also remained unchanged at $0.59, showing no year-over-year change, and it holds a Zacks Rank of 2 (Buy) [6]
Bears are Losing Control Over Wex (WEX), Here's Why It's a 'Buy' Now
ZACKS· 2025-10-09 14:56
Core Viewpoint - Wex (WEX) has shown a downtrend recently, losing 6.2% over the past four weeks, but a hammer chart pattern suggests a potential trend reversal due to increased buying interest [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottom formation, suggesting that selling pressure may be exhausting [2][5]. - This pattern occurs when a stock opens lower, makes a new low, but then finds support and closes near its opening price, signaling a potential reversal of the downtrend [4][5]. - Hammer candles can appear on various timeframes and are utilized by both short-term and long-term investors [5]. Fundamental Analysis - There is rising optimism among Wall Street analysts regarding WEX's future earnings, which supports the potential for a trend reversal [2][7]. - Over the last 30 days, the consensus EPS estimate for WEX has remained unchanged, indicating analysts expect better earnings than previously predicted [8]. - WEX holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].